{"transactions":[{"id":2585861,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-08-31T19:54:18.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":6202,"price":117.3,"value":727494.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.40 to $117.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":13867,"source":{"system":"sec-edgar","filing":"0001209191-21-054050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121054050/doc4.xml","form_type":"4"}},{"id":2837080,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-24T17:10:05.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 5,600 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 4,400 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 1,200 as an additional grant.  Restrictions lapse in 16 equal quarterly installment with the first 350 shares on April 1, 2021 and thereafter with 350 shares on April 1, July 1, October 1 and January 1 of each year with the final 350 shares lapsing on January 1, 2025, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Inclusive of the above 5,600 shares in footnote 1, includes 17, 885 shares which restrictions lapse as to 2,009 shares on each of April 1, July 1 and October 1, 2021; 2,017 shares on January 1, 2022; 1,377 on each of April 1, July 1 and October 1, 2022; 1,380 shares on January 1, 2023; 729 shares on each of April 1, July 1 and October 1, 2023; 743 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2023 and 350 shares on January 1, 2025, if he is employed by the Company on those dates."}],"balance_after":20069,"source":{"system":"sec-edgar","filing":"0001209191-21-013672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121013672/doc4.xml","form_type":"4"}},{"id":2982008,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-13T15:10:05.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":11507,"price":106.12,"value":1221122.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.80 to $106.63, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,469 shares which restrictions lapse as to 2,184 shares on January 1, 2021; 1,659 shares on each of April 1, July 1 and October 1, 2021; 1,667 shares on January 1, 2022; 1,027 shares on each of April 1, July 1 and October 1, 2022; 1,030 shares on January 1, 2023; 379 shares on each of April 1, July 1 and October 1 2023 and 393 shares on January 1, 2024, if he is employed by the Company on those dates."}],"balance_after":14469,"source":{"system":"sec-edgar","filing":"0001209191-20-058215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120058215/doc4.xml","form_type":"4"}},{"id":3225474,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-05T19:20:51.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":6078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 6,078 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 379 shares on April 1, 2020 and thereafter with 379 shares on April 1, July 1, October 1 and January 1 of each year with the final 393 shares lapsing on January 1, 2024, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,976 shares which restrictions lapse as to 2,169 shares on each of April 1, July 1 and October 1, 2020; 2,184 shares on January 1, 2021; 1,659 shares on each of April 1, July 1 and October 1, 2021; 1,667 shares on January 1, 2022; 1,027 shares on each of April 1, July 1 and October 1, 2022; 1,030 shares on January 1, 2023; 379 shares on each of April 1, July 1 and October 1 2023 and 393 shares on January 1, 2024, if he is employed by the Company on those dates."}],"balance_after":25976,"source":{"system":"sec-edgar","filing":"0001209191-20-016491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120016491/doc4.xml","form_type":"4"}},{"id":3437986,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-15T16:57:14.000Z","date":"2019-08-14","kind":"sale","acquired":false,"shares":5000,"price":134.55,"value":672750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.50 to $134.86 per\nshare, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the\nSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of October\n1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on\neach of April 1, July 1 and October 1, 2021; 1,288 on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January\n1, 2023."}],"balance_after":19898,"source":{"system":"sec-edgar","filing":"0001209191-19-046056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119046056/doc4.xml","form_type":"4"}},{"id":3591580,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-18T20:16:19.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":5399,"price":106.63,"value":575695.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.00 to $107.37 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023."}],"balance_after":24898,"source":{"system":"sec-edgar","filing":"0001209191-19-019985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119019985/doc4.xml","form_type":"4"}},{"id":3591579,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-18T20:16:19.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":405,"price":110.1,"value":44590.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023."}],"balance_after":30297,"source":{"system":"sec-edgar","filing":"0001209191-19-019985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119019985/doc4.xml","form_type":"4"}},{"id":3591578,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-18T20:16:19.000Z","date":"2019-03-14","kind":"sale","acquired":false,"shares":400,"price":112.48,"value":44992.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.44 to $112.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023."}],"balance_after":30702,"source":{"system":"sec-edgar","filing":"0001209191-19-019985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119019985/doc4.xml","form_type":"4"}},{"id":3615735,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-05T22:10:16.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":10371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,371 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 648 shares on April 1, 2019 and thereafter with 648 shares on April 1, July 1, October 1 and January 1 of each year with the final 651 shares lapsing on January 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,898 shares, inclusive of the 10,371 shares in footnote 1, of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021; 1288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023."}],"balance_after":31102,"source":{"system":"sec-edgar","filing":"0001209191-19-016713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119016713/doc4.xml","form_type":"4"}},{"id":3852273,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-08-06T20:26:15.000Z","date":"2018-08-03","kind":"sale","acquired":false,"shares":6204,"price":114.81,"value":712281.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $114.10 - $116.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20.731 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 3,102 shares on each of October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022."}],"balance_after":20731,"source":{"system":"sec-edgar","filing":"0001209191-18-045527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118045527/doc4.xml","form_type":"4"}},{"id":3995371,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2018-03-15T21:27:53.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":2900,"price":82.55,"value":239395.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.10 - $82.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1,\n2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1,\n2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1\nand October 1, 2021; and 640 shares on January 1, 2022."}],"balance_after":26935,"source":{"system":"sec-edgar","filing":"0001209191-18-019908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118019908/doc4.xml","form_type":"4"}},{"id":3995370,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-15T14:59:48.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":1179,"price":83.27,"value":98175.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.20 - $83.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022."}],"balance_after":29835,"source":{"system":"sec-edgar","filing":"0001209191-18-019764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118019764/doc4.xml","form_type":"4"}},{"id":3997051,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-14T19:56:06.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":205,"price":85.45,"value":17517.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.45 - $85.55, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022."}],"balance_after":31014,"source":{"system":"sec-edgar","filing":"0001209191-18-019523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118019523/doc4.xml","form_type":"4"}},{"id":3997050,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-14T19:56:06.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":2538,"price":86.16,"value":218674.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 - $86.25, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022."}],"balance_after":31219,"source":{"system":"sec-edgar","filing":"0001209191-18-019523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118019523/doc4.xml","form_type":"4"}},{"id":4009110,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-07T19:44:01.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":10120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,120 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installment with the first 15 installments of 632 shares each beginning on April 1, 2018 and thereafter with 632 shares on April 1, July 1, October 1 and January 1 of each year with the final 640 shares lapsing on January 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the above mentioned shares and 16,185 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":33757,"source":{"system":"sec-edgar","filing":"0001209191-18-017652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118017652/doc4.xml","form_type":"4"}},{"id":4216804,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-09-06T20:01:21.000Z","date":"2017-08-24","kind":"sale","acquired":false,"shares":6599,"price":58.17,"value":383863.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.00 - $59.02, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":26235,"source":{"system":"sec-edgar","filing":"0001209191-17-051587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117051587/doc4.xml","form_type":"4"}},{"id":4220134,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-09-01T20:18:52.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":1594,"price":57,"value":90858.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":30236,"source":{"system":"sec-edgar","filing":"0001209191-17-051055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117051055/doc4.xml","form_type":"4"}},{"id":4220133,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-09-01T20:18:52.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":1004,"price":57.01,"value":57238.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.00- $57.05, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":31830,"source":{"system":"sec-edgar","filing":"0001209191-17-051055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117051055/doc4.xml","form_type":"4"}},{"id":4226939,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-08-23T17:47:07.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":600,"price":59.72,"value":35832.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.70- $59.80, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":32834,"source":{"system":"sec-edgar","filing":"0001209191-17-049905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117049905/doc4.xml","form_type":"4"}},{"id":4226938,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-08-23T17:47:07.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":1064,"price":60.01,"value":63850.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00- $60.05, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 23,637 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,407 on October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":33434,"source":{"system":"sec-edgar","filing":"0001209191-17-049905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117049905/doc4.xml","form_type":"4"}},{"id":4370818,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-28T15:06:28.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":8175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 8,175 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installment with the first 15 installments of 510 shares each beginning on April  1, 2017 and thereafter with 510 on April 1, July 1, October 1 and January 1 of each year with the final 525 shares lapsing on January 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 8,175 shares recently granted and 22,276 of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 3,407 on each of April 1, 2017, July 1, 2017, and October 1, 2017; 3,415 on January 1, 2018; 2,470 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,220 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 510 on each of April 1, July 1 and October 1, 2020; and 525 on January 1, 2021."}],"balance_after":34498,"source":{"system":"sec-edgar","filing":"0001209191-17-023050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117023050/doc4.xml","form_type":"4"}},{"id":4553656,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":135901,"kind":"person","name":"McDowell Glenn","position":1,"cik":"0001315304","reported_name":"McDowell Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-11-16T17:28:56.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":4047,"price":61.15,"value":247474.05,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 26,323 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 4,047 shares on January 1, 2017; 2,897 on each of April 1, 2017, July 1, 2017, and October 1, 2017; 2,905 on January 1, 2018; 1,960 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; and 710 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020."}],"balance_after":26323,"source":{"system":"sec-edgar","filing":"0001209191-16-150412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919116150412/doc4.xml","form_type":"4"}}]}